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Abstract A molecular explanation for the specificity of the
cAMP-dependent protein kinase (PKA) can be provided by its
compartmentalization through association with A-kinase-anchor-
ing proteins (AKAPs). Structural and functional studies have led
to the development of an anchoring model proposing that AKAPs
contain a common PKA binding domain and a unique subcellular
targeting domain. The discovery that AKAPs can bind other
signaling enzymes led to the addition of a third property, that of
scaffolding molecule. Recent research has now expanded the role
of AKAPs to members of multiunit complexes containing both
upstream activators and downstream targets. ß 2000 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
1. Introduction
Some of the best-understood signal transduction pathways
involve the generation of cAMP and the activation of the
cAMP-dependent protein kinase (PKA). Work over the past
40 years has de¢ned numerous transmembrane receptors, het-
erotrimeric G proteins and adenylyl cyclases [1^3]. These mol-
ecules combine to form molecular relay systems that convert
signals transmitted by hormones into the generation of the
intracellular second messenger cAMP. Once generated,
cAMP activates PKA. A tremendous research emphasis to
biochemically characterize the PKA holoenzyme has resulted
in the understanding of its mechanism of catalysis [4], the
identi¢cation of three catalytic subunit and four regulatory
subunit genes [5^7], and the resolution of the crystal structures
of certain R and C subunits [8,9].
Unfortunately, one aspect of PKA action that has remained
elusive is an explanation of how an enzyme with such a broad
range of substrate speci¢city is able to mediate speci¢c phos-
phorylation events at particular sites within the cell. Subcel-
lular targeting of PKA via the association with A-kinase-an-
choring proteins (AKAPs) has emerged as an important
mechanism by which PKA is maintained with distinct subcel-
lular targets [10]. PKA anchoring not only maintains the ki-
nase at its site of action, but also limits access to a subset of
physiological substrates [11]. The discovery that some AKAPs
not only bind PKA but also anchor protein phosphatases has
broadened our view of these molecules. The identi¢cation of
anchored kinase/phosphatase units suggests that some
AKAPs serve as sca¡olding proteins to localize enzymes
that coordinate the phosphorylation status of certain cellular
substrates [12]. In the past year, a new concept of AKAP
signaling networks has emerged from ¢ndings that certain
AKAPs may themselves be recruited into much larger multi-
unit signaling complexes comprising of both upstream activa-
tors and downstream targets [13,14]. Understanding these
complex signaling networks will undoubtedly add to our
knowledge of the speci¢city and regulation of PKA action.
There are 70 AKAP sequences currently known and this
family of proteins represents a functionally related group of
molecules that serve to localize kinases and phosphatases (re-
viewed by [10,15]). In order to highlight progress on this topic,
we have chosen to focus on the AKAP79/150 family. This is a
family consisting of three orthologs; bovine AKAP75, ¢rst
identi¢ed as a contaminant of PKA holoenzyme preparations
[16] ; murine AKAP150, a fragment of which was isolated by
interaction cloning using RII as a probe [17], and human
AKAP79, the prototypic member of the family that was orig-
inally identi¢ed as a component of the postsynaptic densities
in neurons [18]. All three proteins are highly related and di¡er
only in their molecular weights, which is predominantly a
consequence of repeat sequences present in the larger
AKAP150. Since most of the work has been conducted with
AKAP79, it will be used as an example to demonstrate the
complexity and importance of AKAPs in the regulation of
cellular events.
2. Development of the PKA anchoring model: anchoring and
targeting
Studies in the 1970s utilized cAMP binding assays of vari-
ous subcellular fractions to show that the PKA holoenzyme
containing the type I regulatory subunit (RIK or RIL) is pre-
dominantly cytoplasmic, whereas the majority of the type II
PKA holoenzyme containing the type II regulatory subunit
(RIIK or RIIL) is associated with cellular structures and or-
ganelles [19,20]. Later reports described the microtubule-asso-
ciated protein MAP2 and AKAP75 as the ¢rst AKAPs
[16,21]. In both cases, these molecules were originally identi-
¢ed as contaminants of type II PKA holoenzyme preparations
which associated with RII. By the 1990s, structure/function
analysis of AKAPs had demonstrated that only the amino-
terminal regions of the RII dimer were necessary for interac-
tion with MAP2 or AKAP75 [22,23]. These ¢ndings were
consolidated into the original AKAP model which proposed
that each anchoring protein contained two motifs : a PKA
targeting domain and a unique subcellular targeting domain
[24]. The conserved PKA binding domain consists of an am-
phipathic helix which ¢ts into a hydrophobic pocket formed
by the extreme N-terminus of the regulatory subunit [24^26].
In fact, peptides mimicking this amphipathic helix serve as
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e⁄cient anchoring inhibitor reagents that compete for RII^
AKAP interaction in vitro and inside cells [26,27]. These pep-
tides, generically termed Ht31, have been used widely to dem-
onstrate the functional implications of PKA anchoring as it
relates to a growing number of PKA responsive events [10].
The ¢rst functional use of the peptides was by Rosenmund et
al. who reported that intracellular infusion of Ht31 in cultured
hippocampal neurons prevented the PKA-mediated regulation
of AMPA/kainate currents [27]. These results highlighted a
role for PKA anchoring in the regulation of synaptic signaling
events. Although it was unclear at that time which PKA an-
choring event was disrupted by the Ht31 peptides, the subcel-
lular distribution of AKAP79 and its colocalization with these
ion channels made it a prime candidate (Fig. 1).
As stated above, each anchoring protein contains a unique
domain responsible for targeting of the AKAP^PKA complex
[10]. Three N-terminal polybasic sequences in AKAP79 medi-
ate binding to acidic phospholipids and, thus, attachment to
membranes, including postsynaptic sites [28]. Analysis of these
domains identi¢ed phosphorylation sites for PKA and PKC.
Furthermore, activation of PKC was shown to release
AKAP79 from membrane particulate fractions. These ¢ndings
inferred that AKAP79 association with the plasma membrane
may be regulated by phosphorylation, although this has not
been fully established to date. Recent evidence found that
AKAP79 is selectively retained at the post-synaptic densities
in neurons, suggesting that the subcellular localization of
AKAP79 is more complex than originally proposed [14].
Thus, additional targeting determinants that involve pro-
tein^protein interactions are likely to facilitate the precise sub-
cellular location of AKAP79 in neurons.
3. The third property: kinase/phosphatase sca¡olding units
Although AKAPs are de¢ned by their ability to bind PKA,
continuing studies suggest that an equally important function
may be to bind other enzymes (Fig. 2). This provides a mech-
anism for the formation of multicomponent signaling com-
plexes and forces an amendment of the original AKAP model
to incorporate this property. Coghlan et al. initially demon-
strated that the phosphatase calcineurin (PP2B) was an
AKAP79 binding partner through a yeast-2-hybrid screen
[29]. The PP2B binding site was mapped to the C-terminal
region of AKAP79 to a fragment encompassing 108^427 of
the anchoring protein [28]. Interestingly, the association of
PP2B with AKAP79 was shown to inhibit phosphatase activ-
ity in vitro, suggesting that AKAP79 exhibits an additional
level of regulation on the enzyme [29,30]. However, it is hy-
pothesized that when bound to AKAP79, the phosphatase
would be optimally positioned to dephosphorylate substrates,
although the mechanism for activation is at present unknown.
Another enzyme component of the AKAP79 sca¡olding
complex is the calcium/phospholipid-dependent protein kinase
(PKC) [31,32]. Various PKC isoforms associate with AKAP79
through interactions with the conserved catalytic core of the
kinase at a site distinct from both the PP2B and RII binding
domains [33]. Interestingly, binding of the calcium/calmodulin
complex to AKAP79 releases PKC from the anchoring pro-
tein, liberating the active kinase [33,34]. Thus, signals that
proceed through calcium/calmodulin can lead to the liberation
and activation of an anchored pool of PKC at the postsynap-
tic densities [35]. This mechanism demonstrates another fea-
ture of the AKAP79 signaling sca¡old as a site for the inte-
gration of various second messenger signals. This type of
regulation may be particularly relevant at postsynaptic sites
where there is a plethora of signal-generating machinery in-
cluding adenylyl cyclases that produce cAMP, several en-
zymes that generate phospholipids and diacylglycerol and cal-
cium entry through ion channels including NMDA receptors
[35].
The physiological importance of the AKAP79 signaling
complex has also been demonstrated in the rat uterus, where
PKA is a known uterine relaxant which acts via the inhibition
of phospholipase C (PLC) activity [36,37]. Dodge et al. found
that PKA associated with the plasma membrane via binding
to an AKAP, presumably AKAP79, is responsible for this
PKA-mediated inhibition of PLC activity [37]. During preg-
nancy in the rat, PKA-mediated inhibition of PLC activity is
Fig. 1. Subcellular localization of AKAP79 in neurons. The subcel-
lular distribution of AKAP79 at the plasma membrane in neurons
is illustrated. AKAP79 was visualized by immuno£uorescent labeling
using antibodies speci¢c for AKAP79 (green) and the RII subunit
of PKA (blue).
Fig. 2. The AKAP79 signaling complex. An additional property of
AKAPs is their ability to bind not only PKA, but other signaling
enzymes. AKAP79 maintains a signaling sca¡old of PKA, PKC and
PP2B. The signaling complex is attached to the inner face of mem-
branes via association with negatively-charged phospholipids. It is
proposed that these targeting interactions facilitate close association
of these enzymes with target substrates.
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lost on the day of parturition and this loss correlates with a
dramatic decrease in PKA associated with AKAP79 [36]. Fur-
thermore, on the same day of pregnancy, PP2B-associated
AKAP79 is increased. The demonstration that PP2B could
dephosphorylate PLC implicated PP2B in the regulation of
uterine contraction by opposing the uterine relaxation path-
ways. These data suggest the signi¢cance of AKAP79 in reg-
ulating the pathways that control uterine contraction and in
the timing of parturition.
4. The fourth property: recruitment into macromolecular
complexes
Recent advances in our understanding of AKAP79 have
highlighted a previously unappreciated property of the an-
choring protein, namely the ability to be recruited into a larg-
er transduction unit where the signaling complex is physically
associated with upstream activation elements and downstream
substrates (Fig. 3). This represents the fourth postulate of our
anchoring hypothesis. A classical upstream element in PKA
signaling is the L2-adrenergic receptor (L2-AR) [3]. Interest-
ingly, the L2-AR is also a known target for PKA phosphor-
ylation, which is consistent with our idea that many targets of
PKA phosphorylation may be associated with an AKAP sig-
naling complex. Precedence for the association of receptors
and kinases has been de¢ned by studies showing the associa-
tion of activated receptors with G-protein receptor kinases
[38]. However analogous mechanisms for receptor association
with other second messenger kinases have not been elucidated
to date. The recent work of Fraser et al. demonstrates that
AKAP79 coprecipitates with the L2-AR from both cell and
tissue extract, allowing for an extended complex composed of
PKA, PKC, PP2B and the L2-AR [13]. The association of
PKA with the L2-AR was shown to enhance phosphorylation
of the receptor independent of agonist. This action helps to
facilitate a switch in receptor/G-protein coupling from GKs to
GKi, and subsequently stimulates the MAP kinase cascade
[39]. These ¢ndings suggest that L2-AR/AKAP79 association
not only regulates L2-AR signaling pathways, but also the
activation of PKA by switching the L2-AR signaling cascade
from one that stimulates PKA to one that inhibits.
One of the more important downstream actions of PKA is
the regulation of ion channel activity. The AMPA responsive
glutamate receptor in the post-synaptic density is one such
channel, but how PKA is targeted to the ion channel was
unknown [40]. Recently, AKAP79 has been shown to interact
directly with members of the MAGUK family of sca¡olding
molecules, which associate with many proteins in the post-
synaptic densities, including glutamate receptors [14,41].
This interaction was important for PKA phosphorylation of
the ion channel [14]. Thus, the two-fold contact of the MA-
GUK with glutamate receptors and with AKAP79 creates a
protein bridge that links anchored kinases and phosphatases
with their substrates.
5. Conclusions and perspectives
In the past few years, new evidence has deepened our
understanding of AKAPs and the complexity of their signal-
ing networks. Studies on AKAP79 have been instrumental in
these discoveries, and the AKAP model has evolved to en-
compass the growing facets of AKAP79 signaling. The origi-
nal model proposed suggested only two properties of AKAP
function: a PKA binding domain and a targeting domain.
However, the discovery that AKAP79 associated with other
signaling enzymes forced a reevaluation of the function of
AKAPs to that of sca¡olding protein [12]. Now, new research
on AKAP79 will again change the thinking on these multi-
faceted proteins to include the formation of multiunit signal-
ing complexes comprising of both upstream activators and
downstream targets [13,14].
The regulation of AKAP targeting could potentially in£u-
ence the actions of the anchoring protein. The membrane
targeting of AKAP79 appears to be regulated at least in
part by PKC phosphorylation [28]. However, other factors
undoubtedly contribute to this process. For example, the as-
sociation of AKAP79 with MAGUK may contribute to its
localization at the post-synaptic density [14].
Perhaps the most intriguing property of AKAPs is their
potential to assemble signaling complexes through association
with multiple enzymes and binding partners. This idea is illus-
trated by AKAP79, which associates with both the L2-AR
and MAGUK [13,14]. L-Adrenergic stimulation of PKA has
been shown to regulate synaptic ion channels which associate
with MAGUK [42,43]. Therefore, it is conceivable that a
multiunit complex comprising of the L2-AR, AKAP79, MA-
GUK and glutamate receptors may exist at the synapse, which
may be responsible for the adrenergic regulation of the ion
channel (Fig. 3). No doubt future studies will focus on this
possibility, as well as the possibility of similar complexes
formed in other tissues, since AKAP79 displays a broad range
of expression.
The crucial key in the understanding of the physiological
importance of AKAPs will be in the development of knockout
mice. Ablation of the genes encoding the C and RII subunit of
the PKA holoenzyme have demonstrated the importance of
PKA in the regulation of memory formation [44^46]. Since
AKAPs bind the RII subunit of PKA and have been impli-
cated in memory formation, it is conceivable that these ani-
mals would demonstrate de¢ciencies in brain function. Fur-
thermore, these animals would not only demonstrate the
Fig. 3. Schematic diagram of a proposed synaptic signaling unit.
AKAP79 would act as a bridge to link the L2-AR to the glutamate
receptors that associate with MAGUKs. A variety of protein^pro-
tein interactions would act together to maintain the formation of
the multiunit complex that brings together the AKAP79/150 sca¡old
with upstream activators such as the L2-AR and particular sub-
strates for the anchored kinases and phosphatases such as the
AMPA type glutamate receptor ion channels. Each component of
the complex is named.
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importance of PKA anchoring, but also provide a model to
study the roles of the multitude of signaling molecules asso-
ciated with AKAPs.
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